8 ETFs That Have Gained More Than 100% In 2020

Despite the rising COVID-19 cases, Wall Street has been on an astounding rally buoyed by encouraging development in coronavirus vaccines and hopes of their availability soon. This is especially true as the widespread rollout of the vaccine will end the economic crisis and result in swift recovery, leading to higher spending and confidence.

Additionally, reports that lawmakers and the White House are progressing toward a fresh stimulus for the coronavirus-stricken economy has also led to a spike in stocks lately. Further, continued support from the Federal Reserve will continue to drive the stocks higher. The potential for a divided Congress with President-elect Biden also added to the strength. The divided government is favorable for the economy, as there will be lesser chances of major tax increases and tighter regulations.

While the winners have been broad-based, several ETFs have easily crushed the market by wide margins. Below we have presented a bunch of top-performing ETFs from various corners of the market that gained in triple digits from a year-to-date look and will likely continue outperforming, should the trends prevail.

ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) – Up 190.7%

The pandemic has led to a surge in wide acceptance of the next generation of healthcare solutions known as genomics. Additionally, rising government funding, increase in the number of genomics projects, falling sequencing costs, and the entry of new players and start-ups in the genomics field are driving the growth of the market. ARKG is an actively managed ETF that has been the biggest beneficiary of this trend. It focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments along with improvements and advancements in genomics into their business. With AUM of $4.5 billion, the fund holds 48 stocks in its basket and has 0.75% in expense ratio.

1 2 3
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.